Targeted mild hypercapnia is associated with reduced hs-Troponin T release after acute myocardial infarction and out-of-hospital cardiac arrest. A sub-study of the TAME trial.

9 March 2024 (17:08 - 17:20)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Mathias Baumann Melberg

Oslo University Hospital Ulleval, Oslo (Norway)

4 More presentations in this session

Presentation thumbnail

The basal level of inflammation during cardiogenic shock is a strong independent risk marker of mortality.

Professor F. Roubille (Montpellier, FR)

Presentation thumbnail

Dual antiplatelet therapy versus oral anticoagulation plus antiplatelet monotherapy in patients with acute coronary syndrome and coronary artery ectasia: OVER-TIME randomized clinical trial

Doctor D. Araiza Garaygordobil (Ciudad de Mexico, MX)

Presentation thumbnail

Prehospital risk assessment and direct transfer to a percutaneous coronary intervention centre in suspected acute coronary syndrome: 1 year follow-up of the TRIAGE-ACS study

Mr J. Demandt (Eindhoven, NL)

Presentation thumbnail

Early left ventricular unloading or conventional approach after venoarterial extracorporeal membrane oxygenation: One-year outcomes of the EARLY-UNLOAD randomized clinical trial

Assistant Professor Y. Lim (Gwangju, KR)

Access the full session

Session thumbnail

Late-breaking science

The Event

Event poster

ESC Acute CardioVascular Care 2024

9 March 2024 17:08 CET

You may be interested in

Congress Presentation

The effects of targeting mild hypercapnia on right ventricular function after out-of-hospital cardiac arrest. A sub-study of the TAME trial.

Congress Presentation

Ventilation targets after resuscitation: what have we learned from the TAME study?

Congress Session

The best science in cardiac arrest and cardiogenic shock

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources